Skip to main content

Table 1 Baseline characteristics of tiotropium and placebo groups according to different threshold criteria for bronchodilator responsiveness.

From: Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial

 

Criterion A (∆ % Predicted FEV1≥12% and ≥200 mL)

Criterion B (∆ % Predicted FEV1≥15%)

Criterion C (∆ % Predicted FEV1≥10%)

 

Nonresponder (n = 2750)

Responder (n = 3033)

Nonresponder (n = 1995)

Responder (n = 3788)

Nonresponder (n = 3553)

Responder (n = 2230)

 

Tio (n = 1357)

Placebo (n = 1393)

Tio (n = 1520)

Placebo (n = 1513)

Tio (n = 995)

Placebo (n = 1000)

Tio (n = 1882)

Placebo (n = 1906)

Tio (n = 1769)

Placebo (n = 1784)

Tio (n = 1108)

Placebo(n = 1122)

Age (years)

64.9 ± 8.4

65.3 ± 8.4

64.1 ± 8.4

63.8 ± 8.5

64.4 ± 8.3

64.5 ± 8.5

64.5 ± 8.5

64.5 ± 8.5

64.4 ± 8.3

64.6 ± 8.4

64.7 ± 8.6

64.3 ± 8.7

Male, %

69.7

69.2

80.2

78.6

77.0

75.7

74.3

73.2

76.2

75.6

73.7

71.7

Smoking history (%)

            

   Ex-smoker

69.6

70.7

71.6

69.3

67.8

67.5

72.1

71.2

69.3

70.7

72.727.3

68.8

   Current smoker

30.4

29.3

28.4

30.7

32.2

32.5

27.9

28.8

30.7

29.3

 

31.2

Mean COPD duration (years)

10.1 ± 7.7

9.8 ± 7.7

9.7 ± 7.5

9.6 ± 7.0

9.9 ± 7.6

9.7 ± 7.5

9.9 ± 7.5

9.7 ± 7.3

10.1 ± 7.7

9.7 ± 7.5

9.6 ± 7.4

9.6 ± 7.1

Baseline medication* use (%)

            

   LABA

60.0

61.5

59.7

59.1

56.9

59.1

61.4

60.8

59.8

61.7

59.9

57.8

   ICS

62.1

62.5

60.8

60.7

58.9

59.9

62.8

62.4

61.6

61.7

61.2

61.4

   Combination ICS+LABA

49.2

50.0

48.4

47.3

45.2

47.6

50.6

49.1

48.5

49.7

49.1

46.7

   Anticholinergic

46.9

47.6

44.9

42.7

44.0

43.9

46.8

45.6

47.1

45.8

43.9

43.9

   Theophyllines

31.6

33.0

26.3

24.3

29.0

31.4

28.7

27.0

30.7

31.7

25.8

23.4

SGRQ total score (units)

47.2 ± 17.2

48.0 ± 17.5

44.5 ± 16.7

43.9 ± 16.7

45.4 ± 17.5

46.6 ± 17.8

46.0 ± 16.7

45.5 ± 16.9

46.9 ± 17.2

47.1 ± 17.2

44.0 ± 16.6

43.9 ± 17.0

  1. Data expressed as either proportions or mean ± SD.
  2. Tio = tiotropium; LABA = long-acting β-acting agonist; ICS = inhaled corticosteroid; SGRQ = St. George's Respiratory Questionnaire; GOLD = Global Initiative for Chronic Obstructive Lung Disease.
  3. *baseline maintenance inhaled respiratory medication.